Ignite Creation Date:
2024-07-17 @ 12:02 PM
Last Modification Date:
2025-12-16 @ 9:27 PM
Study NCT ID:
NCT06498518
Status:
None
Last Update Posted:
2025-07-11 00:00:00
First Post:
2024-07-02 00:00:00
Brief Title:
A Trial of Gemcitabine, Pembrolizumab and IMM-101 as First Line Treatment in Patients With Metastatic Pancreatic Cancer
Sponsor:
Karen Carty
Organization:
University of Glasgow
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-06-17
Start Date Type:
ACTUAL
Primary Completion Date:
2025-05-23
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-05-23
Completion Date Type:
ACTUAL
First Submit Date:
2024-07-02 00:00:00
First Submit QC Date:
None
Study First Post Date:
2024-07-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-07-08 00:00:00
Last Update Post Date:
2025-07-11 00:00:00
Last Update Post Date Type:
ACTUAL